What is CorMedix's gross unrealized gains?

CorMedix (CRMD) reported gross unrealized gains of $0 in Q4 2025.

How has CorMedix's gross unrealized gains changed year-over-year?

CorMedix's gross unrealized gains decreased by 100.0% year-over-year, from $4K to $0.

What is the long-term trend for CorMedix's gross unrealized gains?

Over 3 years (2022 to 2025), CorMedix's gross unrealized gains has grown at a -100.0% compound annual growth rate (CAGR), from $3.54K to $0.

CorMedix CRMD Gross Unrealized Gains

Gross Unrealized Gains at other companies

Merck & Co.MRK

——

Mirum Pharmaceuticals, Inc.MIRM

——

Rigel PharmaceuticalsRIGL

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's gross unrealized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's gross unrealized gains?: CorMedix (CRMD) reported gross unrealized gains of $0 in Q4 2025.
How has CorMedix's gross unrealized gains changed year-over-year?: CorMedix's gross unrealized gains decreased by 100.0% year-over-year, from $4K to $0.
What is the long-term trend for CorMedix's gross unrealized gains?: Over 3 years (2022 to 2025), CorMedix's gross unrealized gains has grown at a -100.0% compound annual growth rate (CAGR), from $3.54K to $0.